Atlas Trials

Study Evaluating Sodium Selenite in Combination With Abiraterone in Castrate Resistant Prostate Cancer Progressing on Abiraterone

Clinical trial NCT04296578 · WITHDRAWN

Trial details

NCT number
NCT04296578
Sponsor
Stanford University
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Prostate CancerCastrate Resistant Prostate Cancer
Start date
2020-10-01
Primary completion
2022-10-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.